{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:02:28Z","timestamp":1773118948403,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00399-021-00816-w","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T12:46:10Z","timestamp":1635165970000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-world experience with the wearable cardioverter defibrillator: clinical effectiveness and wear-time adherence in patients at high risk for sudden cardiac death","Alltagserfahrungen mit dem tragbaren Kardioverter\/Defibrillator \u2013 klinische Effektivit\u00e4t und Einhaltung der Tragezeit bei Patienten mit hohem Risiko eines pl\u00f6tzlichen Herztods"],"prefix":"10.1007","volume":"33","author":[{"given":"Christian","family":"Weth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Abuazab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Ewen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Ukena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Custodis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"issue":"25","key":"816_CR1","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1056\/NEJMoa043938","volume":"352","author":"SD Solomon","year":"2005","unstructured":"Solomon\u00a0SD, Zelenkofske\u00a0S, McMurray\u00a0JJ et\u00a0al (2005) Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N\u00a0Engl J Med 352(25):2581\u20132588","journal-title":"N Engl J Med"},{"key":"816_CR2","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa041489","volume":"351","author":"SH Hohnloser","year":"2004","unstructured":"Hohnloser\u00a0SH, Kuck\u00a0KH, Dorian\u00a0P et al (2004) Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N\u00a0Engl J Med 351:2481\u20132488","journal-title":"N Engl J Med"},{"key":"816_CR3","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","volume":"361","author":"G Steinbeck","year":"2009","unstructured":"Steinbeck\u00a0G, Andresen\u00a0D, Seidl\u00a0K et\u00a0al (2009) IRIS Investigators. Defibrillator implantation early after myocardial infarction. N\u00a0Engl J Med 361:1427\u20131436","journal-title":"N Engl J Med"},{"key":"816_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ahj.2007.08.010","volume":"155","author":"PF Binkley","year":"2008","unstructured":"Binkley\u00a0PF, Lesinski\u00a0A, Ferguson\u00a0JP et\u00a0al (2008) Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event. Am Heart\u00a0J 155:69\u201374","journal-title":"Am Heart J"},{"key":"816_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ahj.2012.06.009","volume":"164","author":"WA Teeter","year":"2012","unstructured":"Teeter\u00a0WA, Thibodeau\u00a0JT, Rao\u00a0K et al (2012) The natural history of new-onset heart failure with a\u00a0severely depressed left ventricular ejection fraction: implications for timing of implantable cardioverter-defibrillator implantation. Am Heart\u00a0J 164:358\u2013364","journal-title":"Am Heart J"},{"key":"816_CR6","first-page":"306","volume":"7","author":"G Savarese","year":"2019","unstructured":"Savarese\u00a0G, Vedin\u00a0O, D\u2019Amario\u00a0D et\u00a0al (2019) Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure. J\u00a0Am Coll Cardiol 7:306\u2013317","journal-title":"J Am Coll Cardiol"},{"key":"816_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"AE Epstein","year":"2008","unstructured":"Epstein\u00a0AE, DiMarco\u00a0JP, Ellenbogen\u00a0KA et al (2008) ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J\u00a0Am Coll Cardiol 51:e1\u201362","journal-title":"J Am Coll Cardiol"},{"key":"816_CR8","first-page":"1601","volume":"17","author":"SG Priori","year":"2015","unstructured":"Priori\u00a0SG, Blomstrom-Lundqvist\u00a0C, Mazzanti\u00a0A et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 17:1601\u20131687","journal-title":"Europace"},{"key":"816_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jacc.2010.04.016","volume":"56","author":"MK Chung","year":"2010","unstructured":"Chung\u00a0MK, Szymkiewicz\u00a0SJ, Shao\u00a0M et al (2010) Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J\u00a0Am Coll Cardiol 56:194\u2013203","journal-title":"J Am Coll Cardiol"},{"key":"816_CR10","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.jacc.2013.05.086","volume":"62","author":"AE Epstein","year":"2013","unstructured":"Epstein\u00a0AE, Abraham\u00a0WT, Bianco\u00a0NR et al (2013) Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J\u00a0Am Coll Cardiol 62:2000\u20132007","journal-title":"J Am Coll Cardiol"},{"key":"816_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1540-8159.2004.00378.x","volume":"27","author":"AM Feldman","year":"2004","unstructured":"Feldman\u00a0AM, Klein\u00a0H, Tchou\u00a0P et\u00a0al (2004) Use of a\u00a0wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT\/BIROAD. Pacing Clin Electrophysiol 27:4\u20139","journal-title":"Pacing Clin Electrophysiol"},{"key":"816_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.015677","author":"V Kutyifa","year":"2015","unstructured":"Kutyifa\u00a0V, Arthur\u00a0JM, Klein\u00a0H et al (2015) Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II registry). Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015677","journal-title":"Circulation"},{"key":"816_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.115.019124","volume":"134","author":"NK W\u00e4\u00dfnig","year":"2016","unstructured":"W\u00e4\u00dfnig\u00a0NK, G\u00fcnther\u00a0M, Quick\u00a0S et al (2016) Experience with the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circulation 134:635\u2013643","journal-title":"Circulation"},{"issue":"17","key":"816_CR14","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1161\/CIR.0000000000000394","volume":"133","author":"JP Piccini Sr","year":"2016","unstructured":"Piccini\u00a0JP Sr, Allen\u00a0LA, Kudenchuk\u00a0PJ et al (2016) American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the American Heart Association. Circulation 133(17):1715\u20131727","journal-title":"Circulation"},{"issue":"13","key":"816_CR15","first-page":"e210","volume":"138","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ et al (2018) 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 138(13):e210-e271","journal-title":"Circulation"},{"key":"816_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jelectrocard.2017.04.017","volume":"50","author":"T Beiert","year":"2017","unstructured":"Beiert\u00a0T, Malotki\u00a0R, Kraemer\u00a0N et al (2017) A real world wearable cardioverter defibrillator experience\u2014Very high appropriate shock rate in ischemic cardiomyopathy patients at a\u00a0European single-center. J\u00a0Electrocardiol 50:603\u2013609","journal-title":"J Electrocardiol"},{"key":"816_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12872-018-0790-8","volume":"18","author":"S R\u00f6ger","year":"2018","unstructured":"R\u00f6ger\u00a0S, Rosenkraimer\u00a0SL, Hohneck\u00a0A et al (2018) Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a\u00a0real-world setting. BMC Cardiovasc Disord 18:52","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"816_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00392-016-1054-1","volume":"106","author":"JW Erath","year":"2017","unstructured":"Erath\u00a0JW, Vamos\u00a0M, Sirat\u00a0AS, Hohnloser\u00a0SH (2017) The wearable cardioverter-defibrillator in a\u00a0real-world clinical setting: experience in 102\u00a0consecutive patients. Clin Res Cardiol 106(4):300\u2013306","journal-title":"Clin Res Cardiol"},{"key":"816_CR19","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.19102\/icrm.2018.090506","volume":"9","author":"E Nguyen","year":"2018","unstructured":"Nguyen\u00a0E, Weeda\u00a0ER, Kohn\u00a0CG et al (2018) Wearable cardioverter-defibrillators for the prevention of sudden cardiac death: a meta-analysis. J\u00a0Innov Cardiac Rhythm Manag 9:3151\u20133162","journal-title":"J Innov Cardiac Rhythm Manag"},{"issue":"13","key":"816_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1056\/NEJMoa1800781","volume":"379","author":"JE Olgin","year":"2018","unstructured":"Olgin\u00a0JE, Pletcher\u00a0MJ, Vittinghoff\u00a0E et al (2018) Wearable cardioverter-defibrillator after myocardial infarction. N\u00a0Engl J Med 379(13):1205\u20131215","journal-title":"N Engl J Med"},{"issue":"27","key":"816_CR21","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski\u00a0P, Voors\u00a0AA, Anker\u00a0SD et\u00a0al (2016) ESC Scientific Document Group, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart\u00a0J 37(27):2129\u20132200","journal-title":"Eur Heart J"},{"key":"816_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv316","author":"SG Priori","year":"2015","unstructured":"Priori\u00a0SG, Blomstrom-Lundqvist\u00a0C, Mazzanti\u00a0A et al (2015) ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death\u2014web addenda. Eur Heart\u00a0J. https:\/\/doi.org\/10.1093\/eurheartj\/ehv316","journal-title":"Eur Heart J"},{"key":"816_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/europace\/euw180","volume":"19","author":"S Reek","year":"2017","unstructured":"Reek\u00a0S, Burri\u00a0H, Roberts\u00a0PR et al (2017) The wearable cardioverter-defibrillator: current technology and evolving indications. Europace 19:335\u2013345","journal-title":"Europace"},{"key":"816_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jacc.2010.06.059","volume":"57","author":"JB van Rees","year":"2011","unstructured":"van Rees\u00a0JB, Borleffs\u00a0CJ, de Bie\u00a0MK et al (2011) Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J\u00a0Am Coll Cardiol 57:556\u2013562","journal-title":"J Am Coll Cardiol"},{"key":"816_CR25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/jcm9030893","volume":"9","author":"SL Rosenkaimer","year":"2020","unstructured":"Rosenkaimer\u00a0SL, El-Battrawy\u00a0I, Dreher\u00a0TC et al (2020) The wearable cardioverter-defibrillator: experience in 153 patients and a\u00a0long-term follow-up. J\u00a0Clin Med 9:893","journal-title":"J Clin Med"},{"issue":"1","key":"816_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/europace\/euaa268","volume":"23","author":"R Garcia","year":"2021","unstructured":"Garcia\u00a0R, Combes\u00a0N, Defaye\u00a0P et al (2021) Wearable cardioverter-defibrillator in patients with a\u00a0transient risk of sudden cardiac death: the WEARIT-France cohort study. Europace 23(1):73\u201381","journal-title":"Europace"},{"key":"816_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12181-019-0331-4","volume":"13","author":"T Deneke","year":"2019","unstructured":"Deneke\u00a0T, Bosch\u00a0R, Eckardt\u00a0L et\u00a0al (2019) Der tragbare Kardioverter\/Defibrillator (WCD) \u2013 Indikationen und Einsatz. Kardiologe 13:292\u2013304","journal-title":"Kardiologe"},{"key":"816_CR28","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/eurheartj\/eht167","volume":"34","author":"HU Klein","year":"2013","unstructured":"Klein\u00a0HU, Goldenberg\u00a0I, Moss\u00a0AJ (2013) Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Eur Heart\u00a0J 34:2230\u20132242","journal-title":"Eur Heart J"},{"key":"816_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","author":"TA McDonagh","year":"2021","unstructured":"McDonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M et\u00a0al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-021-00816-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-021-00816-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-021-00816-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T15:05:59Z","timestamp":1645715159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-021-00816-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["816"],"URL":"https:\/\/doi.org\/10.1007\/s00399-021-00816-w","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"assertion":[{"value":"16 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.\u00a0Weth, H.\u00a0Abuazab, C.\u00a0Ukena and F.\u00a0Custodis declare that they have no competing interests. S.\u00a0Ewen received speaker or consultant honorarium from Medtronic, Recor, Bayer, Daiichi Sankyo, Boehringer Ingelheim, Novartis, AstraZeneca, Akcea Therapeutics and Bristol Myers Squibb Pfizer Alliance. M.\u00a0B\u00f6hm is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; TTR 219, project number 322900939) and reports personal fees from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cytokinetics, Medtronic, Novartis, Servier and Vifor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}